A Critical Appraisal of the Scientific Basis of Commercial Genomic Profiles Used to Assess Health Risks and Personalize Health Interventions
- 3 March 2008
- journal article
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 82 (3), 593-599
- https://doi.org/10.1016/j.ajhg.2007.12.020
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Genotrim™, a DNA-customized nutrigenomic product, targets genetic factors of obesity: Hypothesizing a dopamine–glucose correlation demonstrating reward deficiency syndrome (RDS)Medical Hypotheses, 2007
- Assessment of cumulative evidence on genetic associations: interim guidelinesInternational Journal of Epidemiology, 2007
- ASHG Statement* on Direct-to-Consumer Genetic Testing in the United StatesAmerican Journal of Human Genetics, 2007
- An exploratory test for an excess of significant findingsClinical Trials, 2007
- On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studiesInternational Journal of Epidemiology, 2006
- Genetic Testing for SaleEpidemiology, 2004
- Genomic profiling to promote a healthy lifestyle: not ready for prime timeNature Genetics, 2003
- Genetic associations: false or true?Trends in Molecular Medicine, 2003
- Replication validity of genetic association studiesNature Genetics, 2001
- Implications of the Human Genome Project for Medical ScienceJama-Journal Of The American Medical Association, 2001